Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beth Detuzzi

Senior Deals Analyst, Strategic Transactions

Connecticut, US
Beth has been with Strategic Transactions for 15 years, performing a variety of roles including researching, analyzing, writing, and editing biopharma and medtech dealmaking summaries for In Vivo. Beth also serves as Editor of the monthly Medical Device Deals Update column for Medtech Insight. She also participates with the sales team and clients on demos to assist with deals/content/searching, and responds to customer deal search queries and ST content questions. Beth holds a Bachelor of Arts degree in Sociology from Sacred Heart University, with a focus on research and analytical writing. In her spare time she enjoys hiking with friends and her two teenagers, and spending time with family.
Advertisement
Set Alert for Articles By Beth Detuzzi

Latest From Beth Detuzzi

Venture Funding Deals: Late Summer Sees Slew Of Series B Mega-Rounds

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in August and September.

Deals Financing

Venture Funding Deals: Korean D&D Raises $137.1m For Subsidiary Model

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in July and August.
Deals Financing

Deals Shaping The Medical Industry, September 2019

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August 2019.

Deals Financing

Venture Funding Deals: July Sees Seven Rounds Of $100m Or More

Century Therapeutics brings in $250m for its cell therapy programs in a series A round, while immunotherapy specialist BioNTech sets a record for series B, raising $350m. Another five firms brought in rounds of $100m or greater...

Deals Financing

Deals Shaping The Medical Industry, August 2019

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced July 2019.

Deals Financing

Deals Shaping the Medical Industry, July 2019

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June 2019.

Deals Financing
See All
Advertisement
UsernamePublicRestriction

Register